After Hours
$
19.20
Change
+0.73 +3.95%
Volume
Volume 42,415
Mar 20, 2023, 5:52 p.m.
Quotes are delayed by 20 min
Today's close
$ 18.14
$ 18.47
Change
+0.33 +1.82%
Day low
Day high
$17.95
$18.64

52 week low
52 week high
$6.00
$19.51

Market cap
$2.31B
Average volume
1.11M
P/E ratio
N/A
Rev. per Employee
$242,728
EPS
-1.16
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NEO
-
NeoGenomics upgraded to buy form hold at Benchmark
- Tomi Kilgore
-
NeoGenomics upgraded to buy from hold at Needham
- Tomi Kilgore
-
NeoGenomics Stock Is Downgraded. A 'Turnaround Appears Daunting.'
- Barron's Online
-
NeoGenomics stock downgraded to hold from buy at Needham
- Emily Bary
-
NeoGenomics downgraded to neutral from buy at BofA Securities
- Tomi Kilgore
-
NeoGenomics stock price target cut to $18 from $25 at BofA Securities
- Tomi Kilgore
-
NeoGenomics stock price target cut to $16 from $26 at Benchmark
- Tomi Kilgore
-
NeoGenomics stock price target cut to $19 from $29 at Needham
- Tomi Kilgore
-
NeoGenomics downgraded to equal weight at Morgan Stanley
- Tomi Kilgore
-
NeoGenomics upgraded to outperform from market perform at Raymond James
- Tomi Kilgore
-
NeoGenomics stock price target cut to $54 from $65 at Truist
- Tomi Kilgore
-
NeoGenomics stock price target cut to $46 from $60 at Benchmark
- Tomi Kilgore
-
NeoGenomics downgraded to market perform from outperform at Raymond James
- Tomi Kilgore
-
NeoGenomics stock price target raised to $64 from $48 at Benchmark
- Tomi Kilgore
-
NeoGenomics started at buy with $65 stock price target at Truist
- Tomi Kilgore
-
NeoGenomics stock price target raised to $48 from $40 at Benchmark
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
Other News on NEO
-
- Edgar Online - (EDG = 10Q, 10K)
-
Invitae: This Turnaround Could Be Painful
- Seeking Alpha
-
CareDx: Organ Transplant Business Falters In Q3
- Seeking Alpha
-
NeoGenomics, Inc. 2022 Q3 - Results - Earnings Call Presentation
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
NeoGenomics, Inc. (NEO) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
TASK and BVS among mid-day movers
- Seeking Alpha
-
Veracyte: The FDA Is Stepping In
- Seeking Alpha
-
NeoGenomics: Market Punishment Continues, But Looks Justified
- Seeking Alpha
-
NeoGenomics cut to Hold at Needham citing longer turnaround
- Seeking Alpha
-
NeoGenomics grants CEO restricted shares, stock options
- Seeking Alpha
-
NeoGenomics, Inc. 2022 Q2 - Results - Earnings Call Presentation
- Seeking Alpha
-
Top 5 2nd Quarter Trades of First Light Asset Management, LLC
- GuruFocus.com
- Loading more headlines...
Press Releases on NEO
-
NeoGenomics Shareholder Action Reminder
- Newsfile Corp
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com